Citation Impact
Citing Papers
Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]
2007
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
2005 StandoutScience
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Complement Factor H Polymorphism in Age-Related Macular Degeneration
2005 StandoutScience
Mononuclear cell complement receptor blockade in primary biliary cirrhosis.
1985
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Multilocus sequence typing
1999
Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis
2013
Diagnostic challenges of early Lyme disease: Lessons from a community case series
2009
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data
2013
Toxoplasmosis
2004 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Cystic fibrosis
2016 Standout
Age-Related Macular Degeneration
2008 Standout
Usefulness of broad-range PCR for the diagnosis of osteoarticular infections
2008
Physiological and pathological aspects of circulating immune complexes
1989
Persistence of antibiotic resistant bacteria
2003
Survey of the year 2004 commercial optical biosensor literature
2005
Population biological principles of drug-resistance evolution in infectious diseases
2011
The Role of Inflammation in the Pathogenesis of Age-related Macular Degeneration
2006
Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe
2010
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
2008
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Paradigm Burgenland: Risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters
2006
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
1987 StandoutNature
Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix
2007
Cystic fibrosis: a mucosal immunodeficiency syndrome
2012
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Vertebral Osteomyelitis
2010 Standout
Complement
2001 Standout
Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis
2013
Survey of the year 2003 commercial optical biosensor literature
2004
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Elucidation of Lyme arthritis
2004
The internal thioester and the covalent binding properties of the complement proteins C3 and C4
1997
Lyme borreliosis
2003
Multifarious roles of sialic acids in immunity
2012
Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
2008
Lyme borreliosis
2011 Standout
Lyme borreliosis in Europe and North America
2004
Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis
2002
Complement-related proteins in pathogenic organisms
1994
The emergence of Lyme disease
2004
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Regulation of macrophage migration by products of the complement system.
1979
Activation of Antibiotic Biosynthesis by Specified Mutations in the rpoB Gene (Encoding the RNA Polymerase β Subunit) of Streptomyces lividans
2002
Molecular Biology and Chemistry of the Alternative Pathway of Complement
1980
The human T-cell receptor α-chain gene maps to chromosome 14
1985 StandoutNatureNobel
Incidence of Toxoplasma gondii Infection in 35,940 Pregnant Women in Norway and Pregnancy Outcome for Infected Women
1998
A NewBorreliaSpecies Defined by Multilocus Sequence Analysis of Housekeeping Genes
2009
In Vitro Susceptibility Testing ofBorrelia burgdorferiSensu Lato Isolates Cultured from Patients with Erythema Migrans before and after Antimicrobial Chemotherapy
2005
Mechanisms by which Activated Macrophages Inhibit Lymphocyte Responses
1978
Serpin Structure, Mechanism, and Function
2002 Standout
Two HLA-linked loci controlling the fourth component of human complement.
1978
Complete primary structures of the E beta chain and gene of the mouse major histocompatibility complex.
1983 StandoutNobel
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
1977
Primary Biliary Cirrhosis
1987 Standout
Third component of human complement: structural requirements for its function
1980
COMPLEMENT-DEPENDENT RELEASE OF IMMUNE COMPLEXES FROM THE LYMPHOCYTE MEMBRANE
1973
Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes.
1980 StandoutNobel
Molecular Typing of Methicillin-Resistant Staphylococcus aureus : Can PCR Replace Pulsed-Field Gel Electrophoresis?
2003
Culture of vascular endothelium.
1976
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.
1988 StandoutNobel
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Permanent cell line expressing human factor VIII-related antigen established by hybridization.
1983 Standout
Common evolutionary origin of alpha 2-macroglobulin and complement components C3 and C4.
1985
Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies.
1979 StandoutNobel
Human DNA ligase I cDNA: cloning and functional expression in Saccharomyces cerevisiae.
1990 StandoutNobel
The complete genomic sequence of Nocardia farcinica IFM 10152
2004 Standout
Expression and Function of Idiotypes on Lymphocytes
1978
Invasive Candidiasis
2015 Standout
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
The Major Histocompatibility Complex of the Mouse
1979 Science
Mouse complement components C3 and C4. Characterization of their messenger RNA and molecular cloning of complementary DNA for C3.
1981
Biological activities of complement-derived peptides
1987
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Clinical Characteristics and Outcomes of Prosthetic Joint Infection Caused by Small Colony Variant Staphylococci
2014
Feedback suppression of the immune response in vitro. I. Activity of antigen-stimulated B cells.
1980 StandoutNobel
Studies on murine Ss protein: demonstration that S region encodes structural gene for fourth component of complement.
1979
Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies.
1980 StandoutNobel
Recurrent idiotopes and internal images.
1982 StandoutNobel
The human complement factor H: functional roles, genetic variations and disease associations
2004
In Vitro Susceptibility of Borrelia spielmanii to Antimicrobial Agents Commonly Used for Treatment of Lyme Disease
2008
Distribution of horseradish peroxidase (HRP)-anti-HRP immune complexes in mouse spleen with special reference to follicular dendritic cells.
1978 StandoutNobel
Antibiotic Management of Methicillin-Resistant Staphylococcus aureus–Associated Acute Pulmonary Exacerbations in Cystic Fibrosis
2015
Plasma membrane polypeptides of resident and activated mouse peritoneal macrophages.
1980
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure
2013
Polyphenolic Substance of Mytilus edulis : Novel Adhesive Containing L-Dopa and Hydroxyproline
1981 StandoutScience
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Characterization of the mRNA and cloned cDNA specifying the third component of mouse complement.
1982
Constitutive expression of a complement-like protein in Toll and JAK gain-of-function mutants ofDrosophila
2000 StandoutNobel
Assignment of the structural gene for the third component of human complement to chromosome 19.
1982
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The induction of macrophage spreading by factor B of the properdin system.
1979
The Biology and Detection of Immune Complexes
1980
Secretory products of macrophages.
1987 Standout
Isolation of cDNA clones specifying the fourth component of mouse complement and its isotype, sex-limited protein.
1984 StandoutNobel
Prospective Surveillance of Community‐Onset and Healthcare‐Associated Methicillin‐Resistant Staphylococcus aureus Isolated from a University‐Affiliated Hospital in Japan
2005
Isolation of a cDNA clone for the human HLA-DR antigen alpha chain by using a synthetic oligonucleotide as a hybridization probe.
1982 StandoutNobel
The biochemistry of complement
1978 NatureNobel
Pathogenesis of Dengue: Challenges to Molecular Biology
1988 StandoutScience
Initial Investigation of Small Colony Variants of Staphylococcus Aureus in Chronic Rhinosinusitis
2015
Third component of human complement: Localization of the internal thiolester bond
1982
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Volker Brade being referenced
Differences of two Borrelia burgdorferi strains in complement activation and serum resistance
1992
Molecular analysis of fusidic acid resistance in Staphylococcus aureus
2003
Immune evasion of Borrelia burgdorferi: mapping of a complement‐inhibitor factor H‐binding site of BbCRASP‐3, a novel member of the Erp protein family
2003
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: What we know, what we don't know, and what we need to know
2006
Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins
2004
Host association of Borrelia burgdorferi sensu lato – the key role of host complement
2002
Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus
2007
Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal–tick infection cycle
2008
Rapid Molecular Typing of Methicillin-ResistantStaphylococcus aureusby PCR-RFLP
2001
Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi
1997
Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistantStaphylococcus aureus
1997
The Responsiveness of Human Vδ1 γδ T Cells toBorrelia burgdorferiIs Largely Restricted to Synovial‐Fluid Cells from Patients with Lyme Arthritis
2002
Superoxide Potently Induces Ceramide Formation in Glomerular Endothelial Cells
2001
New Colorimetric Microdilution Method for In Vitro Susceptibility Testing of Borrelia burgdorferi Against Antimicrobial Substances
2000
Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents — Possible implications for new therapeutic approaches to Lyme disease
2002
Functional characterization of BbCRASP‐2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL‐1
2006
Two cases of chronic arthritis of the forearm due toMycobacterium tuberculosis
1998
Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates
2000
Immune evasion of Borrelia burgdorferi: Insufficient killing of the pathogens by complement and antibody
2002
Improved detection of blood stream pathogens by real-time PCR in severe sepsis
2009
Compensatory Adaptation to the Loss of Biological Fitness Associated with Acquisition of Fusidic Acid Resistance in Staphylococcus aureus
2005
Seroprevalence ofBabesiaInfections in Humans Exposed to Ticks in Midwestern Germany
2002
Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
1974
Konnatale Toxoplasmose mit verzögerter Immunantwort des Kindes: Diagnostische Probleme
2008
Mouse factor B of the alternative pathway of complement activation. I. Purification, characterization, and functional behavior.
1976
Borrelia burgdorferiRegulates Expression of Complement Regulator-Acquiring Surface Protein 1 during the Mammal-Tick Infection Cycle
2005
Molecular Characterization of rpoB Mutations Conferring Cross-Resistance to Rifamycins on Methicillin-Resistant Staphylococcus aureus
1999
Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
1986
Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease
2006
In Vitro Activities of Fluoroquinolones against the SpirocheteBorrelia burgdorferi
2001
The Properdin System: Composition and Function
1978
Factor H family proteins: on complement, microbes and human diseases
2002
Further Characterization of Complement Regulator-Acquiring Surface Proteins ofBorrelia burgdorferi
2001
Quality of Lyme disease serology. Lessons from the German Proficiency Testing Program 1999-2001. A preliminary report.
2002
Identification of Properdin, B, D, and C3 As Biosynthetic Products of Guinea Pig Peritoneal Macrophages and Influence of Culture Conditions on Their Secretion
1978
Interaction of C3b, B, and D in the Alternative Pathway of Complement Activation,
1975
Comparison of In Vitro Activities of Ketolides, Macrolides, and an Azalide against the SpirocheteBorrelia burgdorferi
2003
Linezolid Resistance in Staphylococcus aureus : Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances
2008
Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus
2002
Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
2002
Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.
1978
Studies on the Properdin System: Isolation of a Heat-Labile Factor from Guinea Pig Serum Related to a Human Glycine-Rich Beta-Glycoprotein (Gbg or Factor B)
1972
Inherited Polymorphism of Guinea Pig Factor B and C4: Evidence for Genetic Linkage between the C4 and Bf Loci
1977
Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.
1978
Isolation of Intermediates and Sequential Analysis of the Properdin System: The Role of Factor B
1973
In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages
1976
Rapid Detection of Epidemic Strains of Methicillin-ResistantStaphylococcus aureus
1999
Kinetic Studies of the Formation of the Properdin System Enzymes on Zymosan: Evidence That Nascent C3b Controls the Rate of Assembly
1974
The Thymidine-Dependent Small-Colony-Variant Phenotype Is Associated with Hypermutability and Antibiotic Resistance in Clinical Staphylococcus aureus Isolates
2008
Biosynthesis of pro-C3, a precursor of the third component of complement.
1977
Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3
1992